Michael Benatar Selected Research

Guillain-Barre Syndrome

12/2016

Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Benatar Research Topics

Disease

32	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2022 - 04/2007
24	Myasthenia Gravis 12/2021 - 07/2006
7	Disease Progression 01/2022 - 05/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2013
3	Asymptomatic Diseases 01/2022 - 01/2018
3	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 01/2012
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 02/2015
2	Headache (Headaches) 01/2021 - 12/2017
2	Thymoma (Thymic Carcinoma) 11/2020 - 12/2017
2	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2020 - 01/2011
2	Infections 12/2016 - 05/2010
2	Proteostasis Deficiencies 05/2013 - 03/2013
2	Ischemic Stroke 02/2009 - 01/2008
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Inflammation (Inflammations) 08/2021
1	Meningococcal Infections 01/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019
1	Fatigue 01/2018
1	Meningococcal Meningitis 12/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2017
1	Thymus Neoplasms (Thymus Neoplasm) 12/2017
1	Guillain-Barre Syndrome 12/2016
1	Respiratory Insufficiency (Respiratory Failure) 12/2016
1	Autonomic Nervous System Diseases (Dysautonomia) 12/2016
1	Vascular Diseases (Vascular Disease) 07/2015
1	Autoimmune Diseases (Autoimmune Disease) 04/2015
1	Hypertrophy 02/2015
1	Parkinsonian Disorders (Parkinsonism) 04/2012
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2012
1	Muscular Diseases (Myopathy) 01/2012
1	Nervous System Diseases (Neurological Disorders) 01/2012

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2010
11	Cholinergic ReceptorsIBA 12/2021 - 07/2006
7	Biological ProductsIBA 10/2022 - 05/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
4	Rituximab (Mabthera)FDA Link 12/2021 - 09/2017
4	AntibodiesIBA 01/2021 - 07/2006
4	Prednisone (Sone)FDA LinkGeneric 11/2020 - 03/2016
3	glucose-mannose-glucoseIBA 01/2021 - 01/2019
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2020 - 02/2009
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 06/2007
3	Edrophonium (Tensilon)FDA LinkGeneric 01/2019 - 07/2006
3	Intravenous Immunoglobulins (IVIG)FDA Link 12/2017 - 10/2013
3	SteroidsIBA 07/2016 - 10/2008
3	Valosin Containing ProteinIBA 09/2012 - 12/2010
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2022 - 03/2017
2	margatoxinIBA 11/2020 - 01/2019
2	Complement Inactivating AgentsIBA 01/2020 - 12/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 09/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 12/2012
2	eculizumab FDA Link 01/2019 - 12/2017
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 03/2016 - 02/2008
2	Amino Acids FDA Link 03/2013 - 12/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2010 - 02/2008
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	tofersenIBA 01/2022
1	NeopterinIBA 01/2022
1	EdaravoneIBA 08/2021
1	neonatal Fc receptorIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	rozanolixizumabIBA 01/2021
1	DipeptidesIBA 01/2021
1	ChitinasesIBA 01/2020
1	zilucoplanIBA 01/2020
1	AutoantibodiesIBA 01/2020
1	rho-Associated KinasesIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	fasudil (AT 877)IBA 01/2019
1	Antisense OligonucleotidesIBA 01/2019
1	polyetheretherketoneIBA 01/2018
1	arimoclomolIBA 01/2018
1	Complement System Proteins (Complement)IBA 12/2017
1	Dihydrotachysterol (AT 10)IBA 09/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2017
1	Methotrexate (Mexate)FDA LinkGeneric 07/2016
1	Retinaldehyde (Retinal)IBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	Immunomodulating AgentsIBA 04/2015
1	Cytoplasmic DyneinsIBA 02/2015
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2013
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2013
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 03/2013
1	PrionsIBA 03/2013
1	Superoxide Dismutase-1IBA 03/2013
1	Azathioprine (Imuran)FDA LinkGeneric 12/2012

Therapy/Procedure

17	Therapeutics 01/2022 - 04/2007
6	Thymectomy 11/2020 - 10/2013
2	Activities of Daily Living (ADL) 12/2017 - 07/2016
2	Plasma Exchange 12/2017 - 10/2013
1	Noninvasive Ventilation 12/2016
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2016
1	Immunotherapy 12/2016
1	Plasmapheresis 12/2016
1	Artificial Respiration (Mechanical Ventilation) 12/2016
1	Denervation 02/2015